| Increased cancer risk in patients with periodontitis O Dizdar, M Hayran, DC Guven, TB Yılmaz, S Taheri, AC Akman, E Bilgin, ... Current Medical Research and Opinion 33 (12), 2195-2200, 2017 | 91 | 2017 |
| The association between the pan-immune-inflammation value and cancer prognosis: a systematic review and meta-analysis DC Guven, TK Sahin, E Erul, S Kilickap, T Gambichler, S Aksoy Cancers 14 (11), 2675, 2022 | 69 | 2022 |
| Perspectives, knowledge, and fears of cancer patients about COVID-19 DC Guven, TK Sahin, OH Aktepe, HC Yildirim, S Aksoy, S Kilickap Frontiers in oncology 10, 1553, 2020 | 69 | 2020 |
| Evaluation of cancer risk in patients with periodontal diseases DC Güven, Ö Dizdar, AC Akman, AE BERKER, E Yekedüz, F Ceylan, ... Turkish journal of medical sciences 49 (3), 826-831, 2019 | 66 | 2019 |
| Rituximab experience in patients with long-standing systemic sclerosis–associated interstitial lung disease: a series of 14 patients A Sari, D Guven, B Armagan, A Erden, U Kalyoncu, O Karadag, SA Bilgen, ... JCR: Journal of Clinical Rheumatology 23 (8), 411-415, 2017 | 45 | 2017 |
| Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality DC Guven, TK Sahin, HC Yildirim, E Cesmeci, FGG Incesu, Y Tahillioglu, ... BMJ Supportive & Palliative Care 14 (e1), e456-e461, 2024 | 37 | 2024 |
| COVID-19 pandemic: changes in cancer admissions DC Guven, BY Aktas, MS Aksun, E Ucgul, TK Sahin, HC Yildirim, G Guner, ... BMJ supportive & palliative care 14 (e1), e376-e379, 2024 | 36 | 2024 |
| Antibody responses to COVID-19 vaccination in cancer: a systematic review DC Guven, TK Sahin, S Kilickap, FM Uckun Frontiers in Oncology 11, 759108, 2021 | 34 | 2021 |
| The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis DC Guven, TK Sahin, E Erul, A Rizzo, AD Ricci, S Aksoy, S Yalcin Frontiers in Molecular Biosciences 9, 1039121, 2022 | 33 | 2022 |
| Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients DC Guven, O Dizdar, A Alp, FN Akdoğan Kittana, D Karakoc, ... Biomarkers in medicine 13 (9), 725-735, 2019 | 32 | 2019 |
| HER2-low breast cancer could be associated with an increased risk of brain metastasis DC Guven, MB Kaya, B Fedai, M Ozden, HC Yildirim, K Kosemehmetoglu, ... International Journal of Clinical Oncology, 1-8, 2022 | 27 | 2022 |
| The impact of variant Philadelphia chromosome translocations on the clinical course of chronic myeloid leukemia D Eyüpoğlu, S Bozkurt, İ Haznedaroğlu, Y Büyükaşık, D Güven Turkish Journal of Hematology 33 (1), 60, 2016 | 26 | 2016 |
| PILE: a candidate prognostic score in cancer patients treated with immunotherapy DC Guven, HC Yildirim, E Bilgin, OH Aktepe, H Taban, TK Sahin, IY Cakir, ... Clinical and Translational Oncology 23, 1630-1636, 2021 | 24 | 2021 |
| A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer DC Guven, TK Sahin, HC Yildirim, OH Aktepe, O Dizdar, S Yalcin Critical reviews in oncology/hematology 168, 103528, 2021 | 21 | 2021 |
| Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy DC Guven, MS Aksun, TK Sahin, OH Aktepe, HC Yildirim, H Taban, ... Supportive Care in Cancer 29, 5417-5423, 2021 | 21 | 2021 |
| Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives D C Guven, TK Sahin, O Dizdar, S Kilickap Biomarkers in medicine 14 (14), 1383-1392, 2020 | 18 | 2020 |
| Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications DC Guven, BY Aktas, C Simsek, S Aksoy Future Oncology 16 (9), 497-506, 2020 | 18 | 2020 |
| Impact of therapy in patients with hematologic malignancies on seroconversion rates after SARS-CoV-2 vaccination DC Guven, TK Sahin, S Akın, FM Uckun The Oncologist 27 (4), e357-e361, 2022 | 17 | 2022 |
| The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study DC Guven, R Acar, E Yekeduz, I Bilgetekin, NK Baytemur, C Erol, ... Current Problems in Cancer 45 (6), 100760, 2021 | 16 | 2021 |
| The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma DC Guven, E Erul, F Yilmaz, S Yasar, HC Yildirim, F Ercan, Y Kaygusuz, ... European Archives of Oto-Rhino-Laryngology 280 (5), 2471-2478, 2023 | 14 | 2023 |
Taha Koray SahinHacettepe University Faculty of Medicine, Department of Medical Oncology在 hacettepe.edu.tr 的电子邮件经过验证
